The hypoglycemia-induced AVP release counteracts low plasma concentrations of glucose by gluconeogenic and glycogenolytic effects of AVP in the liver and on the AVP-induced activation of the hypothalamic-pituitary-adrenal cortex axis resulting in glucocorticoid release (Nakamura et al., 2017; Szczepanska-Sadowska et al., 2017). Here, AVP is linked to Hypoglycemia.